Rhythm Pharmaceuticals buy Morgan Stanley
Start price
11.07.25
/
50%
€74.50
Target price
11.07.26
€81.37
Performance (%)
14.77%
Price
16.01.26
€87.50
Summary
This prediction is currently active. The prediction currently has a performance of 14.77%. This prediction currently runs until 11.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 6.061% | 6.061% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was given a new $95.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
11.12.25
11.12.25
-
11.12.26
11.12.26
-14.50%
16.01.26
16.01.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€95.00
16.10.25
16.10.25
€110.50
16.10.26
16.10.26
-10.00%
16.01.26
16.01.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
82.69%
16.01.26
16.01.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24